why choose us

First received: March 14, 2023

Clinical Trial: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Retinitis Pigmentosa

Study Type: INTERVENTIONAL


Official Title: Role of Umbilical Cord-derived Stem Cell Transplantation and Conditioned Medium to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III

Brief Summary: The study will perform UC-MSCs and CM transplantation.There are two groups with different dosages.The first group will be transplanted with 1.5 million cells, meanwhile, the second group is 5 million cells.Each group consists of 15 subjects.All groups will be transplanted via the peribulbar route.All groups will be observed until six months.

Read more